Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity
Standard
Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity. / Marwali, Eva Miranda; Kekalih, Aria; Yuliarto, Saptadi; Wati, Dyah Kanya; Rayhan, Muhammad; Valerie, Ivy Cerelia; Cho, Hwa Jin; Jassat, Waasila; Blumberg, Lucille; Masha, Maureen; Semple, Calum; Swann, Olivia V; Kohns Vasconcelos, Malte; Popielska, Jolanta; Murthy, Srinivas; Fowler, Robert A; Guerguerian, Anne-Marie; Streinu-Cercel, Anca; Pathmanathan, Mohan Dass; Rojek, Amanda; Kartsonaki, Christiana; Gonçalves, Bronner P; Citarella, Barbara Wanjiru; Merson, Laura; Olliaro, Piero L; Dalton, Heidi Jean; ISARIC Characterization Group.
in: BMJ PAEDIATR OPEN, Jahrgang 6, Nr. 1, e001657, 10.2022.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity
AU - Marwali, Eva Miranda
AU - Kekalih, Aria
AU - Yuliarto, Saptadi
AU - Wati, Dyah Kanya
AU - Rayhan, Muhammad
AU - Valerie, Ivy Cerelia
AU - Cho, Hwa Jin
AU - Jassat, Waasila
AU - Blumberg, Lucille
AU - Masha, Maureen
AU - Semple, Calum
AU - Swann, Olivia V
AU - Kohns Vasconcelos, Malte
AU - Popielska, Jolanta
AU - Murthy, Srinivas
AU - Fowler, Robert A
AU - Guerguerian, Anne-Marie
AU - Streinu-Cercel, Anca
AU - Pathmanathan, Mohan Dass
AU - Rojek, Amanda
AU - Kartsonaki, Christiana
AU - Gonçalves, Bronner P
AU - Citarella, Barbara Wanjiru
AU - Merson, Laura
AU - Olliaro, Piero L
AU - Dalton, Heidi Jean
AU - ISARIC Characterization Group
AU - Kobbe, Robin
N1 - © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
PY - 2022/10
Y1 - 2022/10
N2 - BACKGROUND: The impact of the COVID-19 pandemic on paediatric populations varied between high-income countries (HICs) versus low-income to middle-income countries (LMICs). We sought to investigate differences in paediatric clinical outcomes and identify factors contributing to disparity between countries.METHODS: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) COVID-19 database was queried to include children under 19 years of age admitted to hospital from January 2020 to April 2021 with suspected or confirmed COVID-19 diagnosis. Univariate and multivariable analysis of contributing factors for mortality were assessed by country group (HICs vs LMICs) as defined by the World Bank criteria.RESULTS: A total of 12 860 children (3819 from 21 HICs and 9041 from 15 LMICs) participated in this study. Of these, 8961 were laboratory-confirmed and 3899 suspected COVID-19 cases. About 52% of LMICs children were black, and more than 40% were infants and adolescent. Overall in-hospital mortality rate (95% CI) was 3.3% [=(3.0% to 3.6%), higher in LMICs than HICs (4.0% (3.6% to 4.4%) and 1.7% (1.3% to 2.1%), respectively). There were significant differences between country income groups in intervention profile, with higher use of antibiotics, antivirals, corticosteroids, prone positioning, high flow nasal cannula, non-invasive and invasive mechanical ventilation in HICs. Out of the 439 mechanically ventilated children, mortality occurred in 106 (24.1%) subjects, which was higher in LMICs than HICs (89 (43.6%) vs 17 (7.2%) respectively). Pre-existing infectious comorbidities (tuberculosis and HIV) and some complications (bacterial pneumonia, acute respiratory distress syndrome and myocarditis) were significantly higher in LMICs compared with HICs. On multivariable analysis, LMIC as country income group was associated with increased risk of mortality (adjusted HR 4.73 (3.16 to 7.10)).CONCLUSION: Mortality and morbidities were higher in LMICs than HICs, and it may be attributable to differences in patient demographics, complications and access to supportive and treatment modalities.
AB - BACKGROUND: The impact of the COVID-19 pandemic on paediatric populations varied between high-income countries (HICs) versus low-income to middle-income countries (LMICs). We sought to investigate differences in paediatric clinical outcomes and identify factors contributing to disparity between countries.METHODS: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) COVID-19 database was queried to include children under 19 years of age admitted to hospital from January 2020 to April 2021 with suspected or confirmed COVID-19 diagnosis. Univariate and multivariable analysis of contributing factors for mortality were assessed by country group (HICs vs LMICs) as defined by the World Bank criteria.RESULTS: A total of 12 860 children (3819 from 21 HICs and 9041 from 15 LMICs) participated in this study. Of these, 8961 were laboratory-confirmed and 3899 suspected COVID-19 cases. About 52% of LMICs children were black, and more than 40% were infants and adolescent. Overall in-hospital mortality rate (95% CI) was 3.3% [=(3.0% to 3.6%), higher in LMICs than HICs (4.0% (3.6% to 4.4%) and 1.7% (1.3% to 2.1%), respectively). There were significant differences between country income groups in intervention profile, with higher use of antibiotics, antivirals, corticosteroids, prone positioning, high flow nasal cannula, non-invasive and invasive mechanical ventilation in HICs. Out of the 439 mechanically ventilated children, mortality occurred in 106 (24.1%) subjects, which was higher in LMICs than HICs (89 (43.6%) vs 17 (7.2%) respectively). Pre-existing infectious comorbidities (tuberculosis and HIV) and some complications (bacterial pneumonia, acute respiratory distress syndrome and myocarditis) were significantly higher in LMICs compared with HICs. On multivariable analysis, LMIC as country income group was associated with increased risk of mortality (adjusted HR 4.73 (3.16 to 7.10)).CONCLUSION: Mortality and morbidities were higher in LMICs than HICs, and it may be attributable to differences in patient demographics, complications and access to supportive and treatment modalities.
KW - Adolescent
KW - Humans
KW - Child
KW - COVID-19 Testing
KW - Pandemics
KW - COVID-19/epidemiology
KW - Tuberculosis
KW - Health Resources
U2 - 10.1136/bmjpo-2022-001657
DO - 10.1136/bmjpo-2022-001657
M3 - SCORING: Journal article
C2 - 36645791
VL - 6
JO - BMJ PAEDIATR OPEN
JF - BMJ PAEDIATR OPEN
SN - 2399-9772
IS - 1
M1 - e001657
ER -